J. Michael Pearson, Chairman and Chief Executive Officer of Valeant Pharmaceuticals International, Inc. (NYSE: VRX), made the following statements on ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Corporate News Hot Corp. News Litigation Management Comments Momentum Movers

Valeant Pharma (VRX) Halts the Bloodletting Following Conference CallOctober 26, 2015 1:03 PM Valeant (VRX) Answered Its Questions Well, But Other Questions Remain - Deutsche Bank October 26, 2015 11:15 AM Valeant (VRX) CC Seen as Step Forward at BMO Capital But More Needed to Rebuild Investor ConfidenceOctober 26, 2015 10:35 AM UPDATE: Valeant Pharma (VRX) Sees Dramatic Red-to-Green Reversal Then Collapses AgainOctober 26, 2015 9:40 AM Mizuho Provides Quick Thoughts on Valeant (VRX) Slides/CallOctober 26, 2015 9:14 AM Statements Of J. Michael Pearson, Chairman And CEO, And Robert Ingram, Lead Outside Director Of Valeant PharmaceuticalsOctober 26, 2015 9:00 AM